HOSPITAL UNIVERSITARIO RUBER

2023

1. A single-arm study design with non-inferiority and superiority time-to-event endpoints: a tool for proof-of-concept and de-intensification strategies in breast cancer

   Frontiers in Oncology, Vol. 13

2. Absence of Myocardial Involvement After SARS-CoV-2 Vaccination in Asymptomatic Adolescents

   Journal of Cardiovascular Translational Research

3. Alopecia en supervivientes de cáncer de mama en tratamiento con terapia hormonal

   Más dermatología, Núm. 42, pp. 11-12

4. Ambulatory surgery for chronic venous insufficiency using radiofrequency thermoablation: quality and satisfaction

   Cirugia y Cirujanos (English Edition), Vol. 91, Núm. 5, pp. 672-677

5. Analysis of tumor infiltrating CD4+ and CD8+ CDR3 sequences reveals shared features putatively associated to the anti-tumor immune response

   Frontiers in Immunology, Vol. 14

6. Association of HER2DX with pathological complete response and survival outcomes in HER2-positive breast cancer

   Annals of Oncology, Vol. 34, Núm. 9, pp. 783-795

7. Binding Affinity of Trastuzumab and Pertuzumab Monoclonal Antibodies to Extracellular HER2 Domain †

   International Journal of Molecular Sciences, Vol. 24, Núm. 15

8. Capivasertib in Hormone Receptor-Positive Advanced Breast Cancer

   The New England journal of medicine, Vol. 388, Núm. 22, pp. 2058-2070

9. Cardiac Safety and Efficacy of SB3 Trastuzumab Biosimilar for ERBB2-Positive Early Breast Cancer: Secondary Analysis of a Randomized Clinical Trial

   JAMA Network Open, Vol. 6, Núm. 4, pp. E235822

10. Chromatin insulation orchestrates matrix metalloproteinase gene cluster expression reprogramming in aggressive breast cancer tumors

    Molecular Cancer, Vol. 22, Núm. 1

11. Clinical characterization and treatment outcomes of follicular cutaneous immune–related adverse events caused by immune checkpoint inhibitors: A multicenter retrospective study

    Journal of the American Academy of Dermatology, Vol. 88, Núm. 3, pp. 718-720

12. Comparative Cardiac Magnetic Resonance-Based Feature Tracking and Deep-Learning Strain Assessment in Patients Hospitalized for Acute Myocarditis

    Journal of Clinical Medicine, Vol. 12, Núm. 3

13. Cyclin-Dependent Kinase 4/6 Inhibitors and Dermatologic Adverse Events: Results from the EADV Task Force “Dermatology for Cancer Patients” International Study

    Cancers, Vol. 15, Núm. 14

14. Detection of novel therapies using a multi-national, multi-institutional registry of cutaneous immune-related adverse events and management

    International Journal of Dermatology, Vol. 62, Núm. 8, pp. 1020-1025

15. Directional Atherectomy With Antirestenotic Therapy Versus PTA/Supera Stenting for Popliteal Artery Lesions: A Propensity-Matched Analysis

    Journal of Endovascular Therapy

16. Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 cases

    Melanoma research, Vol. 33, Núm. 2, pp. 155-158

17. ER+, HER2− advanced breast cancer treated with taselisib and fulvestrant: genomic landscape and associated clinical outcomes

    Molecular Oncology, Vol. 17, Núm. 10, pp. 2000-2016

18. ESMO expert consensus statements (ECS) on the definition, diagnosis, and management of HER2-low breast cancer

    Annals of Oncology, Vol. 34, Núm. 8, pp. 645-659

19. Efficacy of nirsevimab against respiratory syncytial virus lower respiratory tract infections in preterm and term infants, and pharmacokinetic extrapolation to infants with congenital heart disease and chronic lung disease: a pooled analysis of randomised controlled trials

    The Lancet Child and Adolescent Health, Vol. 7, Núm. 3, pp. 180-189

20. Evaluation of the efficacy of an antioxidant combination for the modulation of metabolic, endocrine, and clinical parameters in patients with polycystic ovary syndrome

    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, Vol. 39, Núm. 1, pp. 2227277